Free Trial

Thermo Fisher Scientific (TMO) News Today

Thermo Fisher Scientific logo
$500.24 +16.48 (+3.41%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$501.00 +0.76 (+0.15%)
As of 08/22/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Why Is Thermo Fisher Scientific Up Today?

Thermo Fisher Scientific Inc. (NYSE:TMO) shares are moving on a mix of operational updates, analyst guidance, and insider trades. Here are the key drivers for investors today:

  • Positive Sentiment: Grand opening of a new 375,000 sq. ft., carbon-neutral manufacturing center in Mebane, North Carolina, boosting pipette-tip production by up to 40 million units per week and reinforcing long-term growth capacity. Thermo Fisher Opens Manufacturing Center
  • Positive Sentiment: William Blair reaffirms an “Outperform” rating on TMO and issues above-consensus EPS forecasts from Q3 2025 through FY 2027, highlighting sustained earnings momentum. William Blair EPS Forecasts
  • Positive Sentiment: Artisan Value Fund’s Q2 2025 letter details conviction in Thermo Fisher’s fundamentals amid market volatility, signaling strong institutional support. Artisan Value Fund Letter
  • Positive Sentiment: A TalkMarkets analysis points to robust momentum, strong profitability, and market positioning at a strategic crossroads, bolstering the bullish case. Earnings Flow & Market Position
  • Neutral Sentiment: Zacks reports TMO is up 1.8% since its last earnings release but questions if this outperformance can be sustained given mixed macro drivers. Up 1.8% Since Earnings
  • Neutral Sentiment: Analysts issue Q3 2025 EPS forecasts in line with Thermo Fisher’s own guidance range, offering little new directional signal. Q3 Earnings Forecasts
  • Neutral Sentiment: MarketBeat includes TMO among “Promising Biotech Stocks To Watch,” reflecting its sector leadership but not necessarily an immediate stock catalyst. Promising Biotech Stocks
  • Neutral Sentiment: A Yahoo Finance piece analyzes how a recent 22% surge in TMO shares affects its valuation framework, providing context but no fresh catalysts. 22% Surge Valuation Analysis
  • Negative Sentiment: CEO Marc Casper sold a total of 496 shares across two transactions (201 shares at $500.17 on Aug 19; 295 shares at $500.04 on Aug 20), trimming his stake by ~0.4% and potentially signaling less insider conviction. CEO Insider Selling
Posted 1+ days agoAI Generated. May Contain Errors.

TMO Latest News

Q3 Earnings Estimate for TMO Issued By William Blair
Thermo Fisher Scientific (NYSE:TMO) CEO Sells $100,534.17 in Stock
Analysts Issue Forecasts for TMO Q3 Earnings
Promising Biotech Stocks To Watch Now - August 19th
Promising Biotech Stocks Worth Watching - August 17th
Get Thermo Fisher Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

TMO Media Mentions By Week

TMO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TMO
News Sentiment

1.25

0.69

Average
Medical
News Sentiment

TMO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TMO Articles
This Week

86

70

TMO Articles
Average Week

Get Thermo Fisher Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:TMO) was last updated on 8/24/2025 by MarketBeat.com Staff
From Our Partners